RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
scPharmaceuticals Stock

scPharmaceuticals Dividend 2024

scPharmaceuticals Dividend

0 USD

scPharmaceuticals Dividend yield

Ticker

SCPH

ISIN

US8106481059

WKN

A2H7XD

How much dividend does scPharmaceuticals 2024 pay?

According to the latest status from November 2024, scPharmaceuticals paid a total of 0 USD per share in dividends within the last 12 months. With the current scPharmaceuticals price of 4.21 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical scPharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the scPharmaceuticals Dividend Safe?

scPharmaceuticals has been increasing the dividend for 0 years.

Over the past 9 years, scPharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding scPharmaceuticals's Dividend Distributions

scPharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining scPharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

scPharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in scPharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

scPharmaceuticals Aktienanalyse

What does scPharmaceuticals do?

scPharmaceuticals Inc is a US pharmaceutical company based in Lexington, Massachusetts. The company was founded in 2013 and currently employs over 100 staff members. It specializes in the development and marketing of innovative drugs for chronic diseases. The company's business model focuses on the development of drugs in the areas of cardiovascular, renal function, and infectious diseases. The goal is to provide better treatment options for patients suffering from chronic diseases than current therapies. The company relies on innovative technologies to improve the effectiveness and tolerability of the developed medications. One of scPharmaceuticals' core areas is cardiovascular therapy. The company is working on the development of a drug called Furoscix™ for the treatment of patients with acute heart failure. Furoscix™ is a convenient, portable infusion system that allows patients to receive the medication at home or in an outpatient facility instead of staying in a hospital. Currently, Furoscix™ is in Phase 3 clinical trials, and results are still pending. Another core area for scPharmaceuticals is kidney therapy. The company is developing a drug called SC-001 for the treatment of patients with chronic kidney insufficiency. SC-001 is a novel medication based on innovative technology that allows the body to break down the drug more slowly, leading to a longer duration of action. Together with other products, such as a midazolam nasal spray for sedation during endoscopies or a fentanyl nasal spray for pain management after surgeries, scPharmaceuticals is working to revolutionize drug therapy and improve patients' quality of life. The company's history is marked by various stages of development. In 2014, scPharmaceuticals received funding of $16.8 million from various investors, including venture capital firms and strategic partners from the pharmaceutical and biotech industry. In 2018, the company went public on the Nasdaq stock exchange and sold shares worth approximately $90 million. These financings enabled the clinical development and future marketing of Furoscix™ and other medications. scPharmaceuticals aims to develop innovative solutions for patients with chronic diseases and provide better treatment options. The company works closely with physicians, hospitals, and patient groups to understand and cater to the needs of its user groups. With advanced technology and the latest medical knowledge, scPharmaceuticals is working to develop the medications of the future. scPharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The scPharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about scPharmaceuticals stock

How much dividend does scPharmaceuticals pay?

Over the past 12 months, scPharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, scPharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of scPharmaceuticals?

The current dividend yield of scPharmaceuticals is .

When does scPharmaceuticals pay dividends?

scPharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of scPharmaceuticals?

scPharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of scPharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is scPharmaceuticals located?

scPharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von scPharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of scPharmaceuticals from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did scPharmaceuticals pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of scPharmaceuticals in the year 2023?

In the year 2023, scPharmaceuticals distributed 0 USD as dividends.

In which currency does scPharmaceuticals pay out the dividend?

The dividends of scPharmaceuticals are distributed in USD.

Andere Kennzahlen von scPharmaceuticals

Our stock analysis for scPharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of scPharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.